This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1994:135:127-33.

doi: 10.1007/978-3-642-85039-4_13.

Aggressive oligodendroglioma: a chemosensitive tumor

J G Cairncross¹

Affiliations

PMID: 8047688
DOI: 10.1007/978-3-642-85039-4_13

Review

Aggressive oligodendroglioma: a chemosensitive tumor

J G Cairncross. Recent Results Cancer Res. 1994.

. 1994:135:127-33.

doi: 10.1007/978-3-642-85039-4_13.

Author

J G Cairncross¹

Affiliation

¹ Department of Clinical Neurological Sciences, University of Western Ontario, London, Canada.

PMID: 8047688
DOI: 10.1007/978-3-642-85039-4_13

No abstract available

PubMed Disclaimer

Similar articles

Aggressive oligodendroglioma: a chemosensitive tumor.
Cairncross JG, Macdonald DR, Ramsay DA. Cairncross JG, et al. Neurosurgery. 1992 Jul;31(1):78-82. doi: 10.1227/00006123-199207000-00011. Neurosurgery. 1992. PMID: 1641113 Review.
[Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].
Bouffet E, Mornex F, Jouvet A, Thiesse P, Mertens P, Helfre S, Sindou M, Bret P. Bouffet E, et al. Bull Cancer. 1997 Oct;84(10):951-6. Bull Cancer. 1997. PMID: 9435796 French.
Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
Levin VA. Levin VA. Oncology (Williston Park). 2015 Apr;29(4):264, 266-8. Oncology (Williston Park). 2015. PMID: 25952490 No abstract available.
Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.
van den Bent MJ, Chinot O, Boogerd W, Bravo Marques J, Taphoorn MJ, Kros JM, van der Rijt CC, Vecht CJ, De Beule N, Baron B. van den Bent MJ, et al. Ann Oncol. 2003 Apr;14(4):599-602. doi: 10.1093/annonc/mdg157. Ann Oncol. 2003. PMID: 12649108 Clinical Trial.
[Chemo-radiotherapy for malignant brain tumors].
Kochi M, Ushio Y. Kochi M, et al. Gan To Kagaku Ryoho. 2002 May;29(5):669-76. Gan To Kagaku Ryoho. 2002. PMID: 12040669 Review. Japanese.

See all similar articles

Cited by

Role of exclusive chemotherapy as first line treatment in oligodendroglioma.
Sunyach MP, Jouvet A, Perol D, Jouanneau E, Guyotat J, Gignoux L, Carrie C, Frappaz D. Sunyach MP, et al. J Neurooncol. 2007 Dec;85(3):319-28. doi: 10.1007/s11060-007-9422-3. Epub 2007 Jun 14. J Neurooncol. 2007. PMID: 17568995
Feline anaplastic oligodendroglioma: long-term remission through radiation therapy and chemotherapy.
Tamura M, Hasegawa D, Uchida K, Kuwabara T, Mizoguchi S, Ochi N, Fujita M. Tamura M, et al. J Feline Med Surg. 2013 Dec;15(12):1137-40. doi: 10.1177/1098612X13488383. Epub 2013 May 7. J Feline Med Surg. 2013. PMID: 23651604 Free PMC article.
Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial.
Taliansky-Aronov A, Bokstein F, Lavon I, Siegal T. Taliansky-Aronov A, et al. J Neurooncol. 2006 Sep;79(2):153-7. doi: 10.1007/s11060-005-9020-1. Epub 2006 Jul 20. J Neurooncol. 2006. PMID: 16855865 Clinical Trial.
Postoperative radiotherapy and chemotherapy in the management of oligodendroglioma: single institutional review of 88 patients.
Ozyigit G, Onal C, Gurkaynak M, Soylemezoglu F, Zorlu F. Ozyigit G, et al. J Neurooncol. 2005 Nov;75(2):189-93. doi: 10.1007/s11060-005-2057-3. J Neurooncol. 2005. PMID: 16132506
On the pathway to success: defining subtypes of gliomas for better treatment selection and refining the meaning of success.
Gilbert MR. Gilbert MR. Curr Oncol Rep. 2013 Feb;15(1):24-6. doi: 10.1007/s11912-012-0282-4. Curr Oncol Rep. 2013. PMID: 23180217

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Supplementary concepts

Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information